Parkinson's disease in twins: A follow-up study

Neurology

Volumn 53, Issue 3, 1999, Pages 566-572

  Vieregge, Peter ^a   Hagenah, J ^a   Heberlein, I ^a   Klein, C ^b   Ludin, H P ^c  

^a UNIVERSITY OF LÜBECK   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIZYGOTIC TWINS; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; LEWY BODY; MALE; MONOZYGOTIC TWINS; ONSET AGE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VERBAL MEMORY;

EID: 0033546640     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.3.566     Document Type: Article

References (40)

1. Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983;33:815-824.
2. Marsden CD. Parkinson's disease in twins. J Neurol Neurosurg Psychiatry 1987;50:105-106.
3. Marttila RJ, Kaprio J, Koskenvuo MD, Rinne UK. Parkinson's disease in a nationwide twin cohort. Neurology 1988;38:1217-1219.
4. Vieregge P, Schiffke KA, Friedrich HJ, Müller B, Ludin HP. Parkinson's disease in twins. Neurology 1992;42:1453-1461.
5. 18F-Dopa and positron emission tomography. Neurology 1992;42:1894-1900.
6. Holthoff VA, Vieregge P, Kessler J, et al. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994;36: 176-182.
7. Lazzarini AM, Myers RH, Zimmerman TR Jr, et al. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994;44:499-506.
8. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 1991;18:275-278.
9. Duvoisin RC. The genetics of Parkinson's disease. A review. Adv Neurol 1993;60:306-315.
10. Gonera EG, van't Hof M, Berger HJC, van Weel C, Horstink MWIM. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 1997;12:871-876.
11. Heberlein I, Ludin H-P, Scholz J, Vieregge P. Personality, depression and premorbid life-style in twin pairs discordant for Parkinson's disease. J Neurol Neurosurg Psychiatry 1998; 64:262-266.
12. Duvoisin RC, Johnson WG. Hereditary Lewy-body Parkinsonism and evidence for a genetic etiology of Parkinson's disease. Brain Pathol 1992;2:309-320.
13. 18F)dopa PET. J Neurol Neurosurg Psychiatry 1998;64:314-319.
14. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
15. 18F-dopa PET study. Neurology 1992;42:1554-1560.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd rev. ed. Washington, DC: American Psychiatric Association, 1987.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;2:189-198.
18. Fahn S, Elton RL, members of the UPDRS development committee: Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease. Vol. II. Florham Park, NJ: Macmillan Healthcare Information, 1987:153-163.
19. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
20. Bentivoglio AR, Bressman SB, Cassetta E, Carretta D, Tonali P, Albanese A. Analysis of blink rate patterns in normal subjects. Mov Disord 1997;12:1028-1034.
21. Wechsler D. Handanweisung zum Hamburg-Wechsler-Intelligenztest fur Erwachsene (HAWIE). Bern: Verlag Hans Huber, 1991.
22. Lezak M. Neuropsychological assessment, 3rd ed. New York: Oxford University Press, 1995.
23. Levin BE, Llabre MM, Weiner WJ. Cognitive impairments associated with early Parkinson's disease. Neurology 1989;39: 557-561.
24. Dufeu P, Kühn S, Schmidt LG. Prüfung der Gütekriterien einer deutschen Version des "Tridimensional personality Questionnaire (TPQ)" von Cloninger bei Alkoholabhängigen Sucht 1995;41:395-407.
25. Bullinger M, Kirchberger I, Ware J. Der deutsche SF - 36 Health Survey. Zeitschr f Gesundheitswiss 1995;3:21-36.
26. Ivnik RJ, Malec JF, Smith GE, et al. Mayo's older Americans normative studies: updated AVLT norms for ages 56 to 97. Clin Neuropsychologist 1992;6:83-104.
27. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Neurology 1996;47:1113-1124.
28. Vieregge P. Genetic factors in the etiology of idiopathic Parkinson's disease. J Neural Transm PD Sect 1994;8:1-37.
29. Breitner JCS, Welsh KA, Gau BA, et al. Alzheimer's disease in the National Academy of Sciences - National Research Council Registry of aging twin veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995;52:763-771.
30. Vieregge P, Heberlein I, Kömpf D. Are neuropsychological tests useful to screen for the genetic risk of Parkinson's disease? Parkinsonism Rel Disord 1997;3:141-150.
31. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991;114:2095-2122.
32. Taylor AE, Saint-Cyr JA, Lang AE. Memory and learning in early Parkinson's disease: evidence for a "frontal lobe syndrome." Brain Cogn 1990;13:211-232.
33. Stern Y, Tetrud JW, Martin WRW, Kutner SJ, Langston JW. Cognitive change following MPTP exposure. Neurology 1990; 40:261-264.
34. Schneider JS, Pope-Colman A. Cognitive deficits precede motor deficits in a slowly progressive model of Parkinsonism in the monkey. Neurodegeneration 1995;4:245-255.
35. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
36. Sommer SS, Rocca WA. Prion analogues and twin studies in Parkinson's disease. Neurology 1996;46:273-275.
37. Gasser T, Müller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13 Nat Genet 1998;18:262-265.
38. Krüger R, Kühn W, Müller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998;18:106-108.
39. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-452.
40. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 1998;392:605-608.